FMR1 and fragile X-associated tremor/ataxia syndrome: Thus a key hypothesis is that FMR1 mRNA gain-of-function toxicity may underlie FXPOI, as is thought to be the case in the other premutation associated disorder, FXTAS (Hagerman and Hagerman, 2002) (Fig. 2A).